Association of leukocyte telomere length with type 2 diabetes in mainland Chinese populations

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1371-1374

  Shen, Qin ^a,b   Zhao, Xinzhi ^a   Yu, Lan ^b   Zhang, Zhou ^b   Zhou, Daizhan ^b   Kan, Mengyuan ^b   Zhang, Di ^b   Cao, Lan ^a   Xing, Qinghe ^a   Yang, Yifeng ^b   Xu, He ^b   He, Lin ^a,b,c   Liu, Yun ^a  

^a FUDAN UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; CHINESE; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DRINKING BEHAVIOR; FEMALE; GENE DOSAGE; GENETIC ASSOCIATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; TELOMERE HOMEOSTASIS;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; TELOMERE; TELOMERE SHORTENING; URBAN HEALTH;

EUKARYOTA;

EID: 84859538309     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1562     Document Type: Article

References (18)

1. Bjelakoviæ G, Beninati S, Pavloviæ D, Kociæ G, Jevtoviæ T, Kamenov B, Saranac LJ, Bjelakoviæ B, Stojanoviæ I, Basiæ J 2007 Glucocorticoids and oxidative stress. J Basic Clin Physiol Pharmacol 18:115-127 (Pubitemid 47205361)
2. Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA 2006 Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 29:283-289 (Pubitemid 44106505)
3. Autexier C, Lue NF 2006 The structure and function of telomerase reverse transcriptase. Annu Rev Biochem 75:493-517 (Pubitemid 44118041)
4. Zee RY, Castonguay AJ, Barton NS, Germer S, Martin M 2010 Mean leukocyte telomere length shortening and type 2 diabetes mellitus: a case-control study. Transl Res 155:166-169
5. Salpea KD, Talmud PJ, Cooper JA, Maubaret CG, Stephens JW, Abelak K, Humphries SE 2010 Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 209:42-50
6. Adaikalakoteswari A, Balasubramanyam M, Mohan V 2005 Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabet Med 22:1151-1156 (Pubitemid 41224172)
7. Kejariwal D, Stepien KM, Smith T, Kennedy H, Hughes DA, Sampson MJ 2008 Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control. BMC Endocr Disord 8:12
8. Liu Y, Yu L, Zhang D, Chen Z, Zhou DZ, Zhao T, Li S, Wang T, Hu X, Feng GY, Zhang ZF, He L, Xu H 2008 Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia 51:2134-2137
9. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553 (Pubitemid 28319935)
10. Mather KA, Jorm AF, Milburn PJ, Tan X, Easteal S, Christensen H 2010 No associations between telomere length and age-sensitive indicators of physical function in mid and later life. J Gerontol A Biol Sci Med Sci 65:792-799
11. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB 2003 Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24:77-84 (Pubitemid 35454145)
12. von Zglinicki T, Serra V, Lorenz M, Saretzki G, Lenzen-Grossimlighaus R, Gessner R, Risch A, Steinhagen-Thiessen E 2000 Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest 80:1739-1747
13. Shen J, Gammon MD, Wu HC, Terry MB, Wang Q, Bradshaw PT, Teitelbaum SL, Neugut AI, Santella RM 2010 Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev 19:219-228
14. Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, Bingham SA, Ponder BA, Pharoah PD, Khaw KT, Easton DF, Dunning AM 2010 Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 70:3170-3176
15. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM 2007 Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 67:5538-5544 (Pubitemid 46997296)
16. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, Gallaher JL, Reid BJ, Rabinovitch PS 2007 Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 16:2649-2655 (Pubitemid 351210548)
17. Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, Kim CH, Kam S, Jung TH, Park JY 2008 Telomere length and the risk of lung cancer. Cancer Sci 99:1385-1389 (Pubitemid 351761728)
18. Hamel FG 2010 Telomeres and type 2 diabetes. Transl Res 155:164-165